Acute disseminated encephalomyelitis history and symptoms: Difference between revisions
Line 25: | Line 25: | ||
*[[Agraphia]], [[aphasia]], [[alexia]], [[acalculia]] | *[[Agraphia]], [[aphasia]], [[alexia]], [[acalculia]] | ||
*[[Sensory]] [[symptoms]]: [[Astereognosis]] ,[[agraphesthesia]], loss of [[proprioception]], [[vibration]] and [[temperature]] [[sensation]] | *[[Sensory]] [[symptoms]]: [[Astereognosis]] ,[[agraphesthesia]], loss of [[proprioception]], [[vibration]] and [[temperature]] [[sensation]] | ||
*[[Brainstem]] [[involvement]] (carries a poorer [[prognosis]] and a higher risk of [[fulminant]] [[disease]] course): [[Diplopia]], [[dysphagia]], [[dysarthria]], [[vertigo]], [[hearing]] loss, loss of [[taste]] and [[smell]] | *[[Brainstem]] [[involvement]] (carries a poorer [[prognosis]] and a higher risk of [[fulminant]] [[disease]] course<ref name="pmid18272282">{{cite journal| author=Tenembaum SN| title=Disseminated encephalomyelitis in children. | journal=Clin Neurol Neurosurg | year= 2008 | volume= 110 | issue= 9 | pages= 928-38 | pmid=18272282 | doi=10.1016/j.clineuro.2007.12.018 | pmc=7116932 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18272282 }} </ref>): [[Diplopia]], [[dysphagia]], [[dysarthria]], [[vertigo]], [[hearing]] loss, loss of [[taste]] and [[smell]]<ref name="pmid27572859">{{cite journal| author=Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S | display-authors=etal| title=Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. | journal=Neurology | year= 2016 | volume= 87 | issue= 9 Suppl 2 | pages= S38-45 | pmid=27572859 | doi=10.1212/WNL.0000000000002825 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27572859 }} </ref> | ||
====[[Meningism]]==== | ====[[Meningism]]==== | ||
Caused by [[lymphocytic]] [[infiltration]] of the [[meninges]] in 26-31% of [[cases]] | Caused by [[lymphocytic]] [[infiltration]] of the [[meninges]] in 26-31% of [[cases]] |
Revision as of 06:41, 17 November 2022
Acute disseminated encephalomyelitis Microchapters |
Differentiating Acute disseminated encephalomyelitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute disseminated encephalomyelitis history and symptoms On the Web |
American Roentgen Ray Society Images of Acute disseminated encephalomyelitis history and symptoms |
FDA on Acute disseminated encephalomyelitis history and symptoms |
CDC on Acute disseminated encephalomyelitis history and symptoms |
Acute disseminated encephalomyelitis history and symptoms in the news |
Blogs on Acute disseminated encephalomyelitis history and symptoms |
Directions to Hospitals Treating Acute disseminated encephalomyelitis |
Risk calculators and risk factors for Acute disseminated encephalomyelitis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
ADEM has an abrupt onset and a monophasic course. Symptoms usually begin 1-3 weeks after infection or vaccination. Major symptoms include fever, headache, drowsiness, seizures and coma. Although initially the symptoms are usually mild, later in the course of the disease patients may even die, if they are not treated properly. Some patients recover completely, while others have permanent neurological impairments.
History
Classic ADEM is monophasic, with a history of usually a preceding illness or less commonly, a vaccination. It is characterised by an acute onset of focal neurologic symptoms, often with rapid deterioration of consciouness, after a variable latent period of several days to few months.
Symptoms
Typical
Prodromal symptoms
- Identical in adults and children
- Headache
- Fever, malaise
- Irritability
- Nausea and vomiting
- General neurological symptoms after 2-5 days[1]
Altered mental status
- Features of [encephalopathy]] comprising changes in behaviour and consciousness (46-73% of pediatric patients and 20-56% of adult cases)[2] ranging in severity from lethargy to coma. Presence of encephalopathy differentiates pediatric ADEM from Multiple Sclerosis[3].
- Confusion
- Psychosis
Focal neurological symptoms
- Damage to occipital lobes: Homonymous visual field defects, cortical blindness
- Agraphia, aphasia, alexia, acalculia
- Sensory symptoms: Astereognosis ,agraphesthesia, loss of proprioception, vibration and temperature sensation
- Brainstem involvement (carries a poorer prognosis and a higher risk of fulminant disease course[4]): Diplopia, dysphagia, dysarthria, vertigo, hearing loss, loss of taste and smell[1]
Meningism
Caused by lymphocytic infiltration of the meninges in 26-31% of cases
References
- ↑ 1.0 1.1 Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S; et al. (2016). "Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome". Neurology. 87 (9 Suppl 2): S38–45. doi:10.1212/WNL.0000000000002825. PMID 27572859.
- ↑ Marchioni E, Ravaglia S, Montomoli C, Tavazzi E, Minoli L, Baldanti F; et al. (2013). "Postinfectious neurologic syndromes: a prospective cohort study". Neurology. 80 (10): 882–9. doi:10.1212/WNL.0b013e3182840b95. PMID 23325908.
- ↑ Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC; et al. (2013). "International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions". Mult Scler. 19 (10): 1261–7. doi:10.1177/1352458513484547. PMID 23572237.
- ↑ Tenembaum SN (2008). "Disseminated encephalomyelitis in children". Clin Neurol Neurosurg. 110 (9): 928–38. doi:10.1016/j.clineuro.2007.12.018. PMC 7116932 Check
|pmc=
value (help). PMID 18272282.